Connect
MJA
MJA

Prolonged tumour growth after treatment of infantile haemangioma with propranolol

Roderic J Phillips, Catherine M Crock, Anthony J Penington and Philip S Bekhor
Med J Aust 2017; 206 (3): 131. || doi: 10.5694/mja16.00846
Published online: 20 February 2017

Infantile haemangioma is the most common tumour of infancy, sometimes requiring treatment because of the risk of functional impairment or permanent scarring. Growth usually ceases by 12 months of age, and the tumour gradually regresses. In 2008, a review of all patients previously seen in seven international treatment centres identified only five children in whom any haemangioma growth was seen beyond 2 years of age, and none beyond 4 years.1

  • Roderic J Phillips1,2
  • Catherine M Crock1
  • Anthony J Penington1,3
  • Philip S Bekhor1

  • 1 Royal Children's Hospital, Melbourne, VIC
  • 2 Monash University, Melbourne, VIC
  • 3 Murdoch Childrens Research Institute, Melbourne, VIC

Correspondence: rod.phillips@me.com

Competing interests:

No relevant disclosures.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.